biocatalysis

FBL pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ‘orally active’ therapeutic alternative for COVID 19

This novel technology using green chemistry provides a sustainable, efficient and scalable form of treatment  to fight against COVID 19   New…

3 years ago

WuXi STA to build new R&D center in Shanghai

New Delhi, April 30, 2018: WuXi STA has already established an industry leading process development platform with over 1,000 scientists…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420